HCAT vs. TBLA, DCBO, SPT, EVER, DAVA, KIND, SMWB, VTEX, HUYA, and CINT
Should you be buying Health Catalyst stock or one of its competitors? The main competitors of Health Catalyst include Taboola.com (TBLA), Docebo (DCBO), Sprout Social (SPT), EverQuote (EVER), Endava (DAVA), Nextdoor (KIND), Similarweb (SMWB), VTEX (VTEX), HUYA (HUYA), and CI&T (CINT). These companies are all part of the "computer software" industry.
Health Catalyst vs. Its Competitors
Health Catalyst (NASDAQ:HCAT) and Taboola.com (NASDAQ:TBLA) are both small-cap computer software companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.
Taboola.com has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Taboola.com, indicating that it is currently the more affordable of the two stocks.
Taboola.com has a net margin of 0.75% compared to Health Catalyst's net margin of -31.67%. Taboola.com's return on equity of 5.27% beat Health Catalyst's return on equity.
Health Catalyst presently has a consensus price target of $5.82, indicating a potential upside of 59.40%. Taboola.com has a consensus price target of $4.50, indicating a potential upside of 34.33%. Given Health Catalyst's higher probable upside, research analysts plainly believe Health Catalyst is more favorable than Taboola.com.
85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 42.9% of Taboola.com shares are held by institutional investors. 2.6% of Health Catalyst shares are held by insiders. Comparatively, 24.7% of Taboola.com shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Health Catalyst has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Comparatively, Taboola.com has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500.
In the previous week, Taboola.com had 1 more articles in the media than Health Catalyst. MarketBeat recorded 9 mentions for Taboola.com and 8 mentions for Health Catalyst. Taboola.com's average media sentiment score of 0.81 beat Health Catalyst's score of 0.63 indicating that Taboola.com is being referred to more favorably in the news media.
Summary
Taboola.com beats Health Catalyst on 11 of the 15 factors compared between the two stocks.
Get Health Catalyst News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Health Catalyst Competitors List
Related Companies and Tools
This page (NASDAQ:HCAT) was last updated on 8/29/2025 by MarketBeat.com Staff
MarketBeat All Access